AccuPower® HPV Genotyping Kit
The global incidence and death rates of cervical cancer rank the second and third highest respectively among women.
It adds 4,000 ~ 5,000 new cases every year and the incidence rates in young women are increasing. The main cause of cervical cancer is
Human papillomavirus (HPV) that infects cervix. HPV is known to be responsible for more than 90% of cervical cancer.
According to the domestic study with 196 patients in cervical adenocarcinoma, HPV genotype 18 was responsible for the disease
in 54.2% of the patients; HPV 16, in 44.1%; HPV 45, in 3.4%. HPV genotype 16 and 18 account for 60~70% of cervical cancer worldwide
and are reported to be a risk factor to develop cervical intraepithelial neoplasia (CIN) with 30% probability.
The AccuPower® HPV Genotyping Kit is an in vitro diagnostic kit designed for the simultaneous detection of
27 Human Papillomavirus genotypes in human cervical/vaginal swab samples through real-time polymerase chain reaction (PCR).
The kit is configured for use with Exicycler™ 96.